Pharmaceutical sector changes
The Polish medicines policy is expected to undergo revolutionary changes in the coming months
– From the point of view of medicine producers, the dilemmas and challenges, which are faced by the Polish Minister of Health, are enormous today – said Jerzy Toczyski, President of GlaxoSmithKline Pharmaceuticals in Poland during a panel „Effective cooperation for the benefit of health”. – Prices, for both innovative and generic medicines, belong to...
Archiwum to wszystkie treści publikowane w "Rzeczpospolitej" od 1993 roku.
Ponad milion tekstów w jednym miejscu.
Zamów dostęp do pełnego Archiwum "Rzeczpospolitej"
ZamówUnikalna oferta


![[?]](https://static.presspublica.pl/web/rp/img/cookies/Qmark.png)